Premium
Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy
Author(s) -
Linggonegoro Danny W.,
McCormack Lindsay,
Grenier PierreOlivier,
Vrooman Lynda M.,
Devlin Phillip M.,
Huang Jennifer T.
Publication year - 2021
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14585
Subject(s) - medicine , anaplastic large cell lymphoma , lymphoma , brachytherapy , cd30 , radiation therapy , dermatology , pathology , surgery
Primary cutaneous anaplastic large cell lymphoma (PC‐ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC‐ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6‐year‐old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow‐up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.